Company intelligence / Profile preview

Blue-Zone Technologies

Ownership: Private
Development stage: Other

Overview

Blue-Zone Technologies is a pioneer in cleantech pharmaceutical solutions, specializing in capturing, recycling, and purifying waste halogenated anesthetic gases from healthcare facilities. Their patented technologies enable the production of sustainable branded generic inhalation anesthetic drugs while reducing greenhouse gas emissions. The company operates a licensed pharmaceutical plant to manufacture these products[1][2][3].

Therapeutic areas: Other
Modalities: Small molecule (inhalation anesthetics)Device (waste anesthetic gas recovery systems)
Industry: Biotech

Partnerships

Class 1 Incorporated ("Class 1"), Canada [3]

Beyond the preview

Go deeper on Blue-Zone Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blue-Zone Technologies.

Explore the full profile